A PHARMACODYNAMIC COMPARISON OF PRASUGREL VERSUS TICAGRELOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CORONARY ARTERY DISEASE: THE OPTIMUS (OPTIMIZING ANTIPLATELET THERAPY IN DIABETES MELLITUS)-4 STUDY

A PHARMACODYNAMIC COMPARISON OF PRASUGREL VERSUS TICAGRELOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CORONARY ARTERY DISEASE: THE OPTIMUS (OPTIMIZING ANTIPLATELET THERAPY IN DIABETES MELLITUS)-4 STUDY

Methods This was a prospective, randomized, crossover PD study conducted in aspirin-treated DM patients (n=50) with coronary artery disease (CAD).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-04, Vol.67 (13), p.22-22
Hauptverfasser: Franchi, Francesco, Rollini, Fabiana, Duarte, Valeria, Cho, Jung Rae, Aggarwal, Niti, Hu, Jenny, Kureti, Megha, Durairaj, Ashwin, Been, Latonya, Zenni, Martin, Guzman, Luis A, Bass, Theodore, Angiolillo, Dominick
Format: Artikel
Sprache:eng
Schlagworte:
Blood platelets
Cardiology
Cardiovascular
Cardiovascular disease
Circulatory system
Coronary vessels
Diabetes
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods This was a prospective, randomized, crossover PD study conducted in aspirin-treated DM patients (n=50) with coronary artery disease (CAD).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(16)30023-7